Fig. 1From: The clinical value of metabolic syndrome and its components with respect to sudden cardiac death using different definitions: Two decades of follow-up from the Tehran Lipid and Glucose StudyCumulative incidence of sudden cardiac death by metabolic syndrome status at baseline according to the ATP III A, JIS B, IDF C, and WHO D criteriaBack to article page